Medical dictionary

Medical terminology normalized via MeSH, ICD-11, SNOMED CT.

62,341 terms indexed

• C5841774-(3,4-dimethoxyphenyl)benzyl etherMeSH

  structure in first source

• C5771094-(3,4-dimethyl-2,5-dioxo-4-(4-hydroxyphenyl)imidazolidin-1-yl)-2-(trifluoromethyl)benzonitrileMeSH

  structure in first source

• C5726224-(3,5-bis(2-chlorobenzylidene)-4-oxopiperidine-1-yl)-4-oxo-2-butenoic acidMeSH

  has antineoplastic activity; structure in first source

• C5875424-(3,5-bis(benzyloxy)phenyl)-6-(5-chloro-2-hydroxyphenyl)-2-oxo-1,2-dihydropyridine-3-carbonitrileMeSH

  a survivin modulator; structure in first source

• C5842024-(3-((3-fluoro-4-(1-methyl-1H-pyrazol-5-yl)phenyl)thio)phenyl)tetrahydro-2H-pyran-4-carboxamideMeSH
• C5870044-(3-((3-hydroxy-2-(oct-2-enyl)-5-oxocyclopentylidene)methyl)oxiran-2-yl)butanoic acidMeSH

  structure in first source

• C5781834-(3-((5-(2-fluoroethoxy)pyridin-2-yl)oxy)benzylidene)-N-(pyridazin-3-yl)piperidine-1-carboxamideMeSH

  a PET imaging agent for brain fatty acid amide hydrolase; structure in first source

• C5720604-(3-(1-(2-(4-(2,4-dimethoxybenzoyl)phenoxy)acetyl)piperidin-4-yl)propyl)-N-(4-fluorophenyl)piperidine-1-carboxamideMeSH

  has antineoplastic activity; structure in first source

• C5744444-(3-(2,6-dimethylpyridin-4-yl)phenyl)-7-methyl-8-trifluoromethyl-1,3-dihydrobenzo(b)(1,4)diazepin-2-oneMeSH

  an antagonist of both mGluR2 and mGluR3; structure in first source

• C5855544-(3-(2-(2-(4-acetoxy-3,5-dimethoxybenzoyloxy)ethoxy)ethylamino)-3-oxoprop-1-enyl)-1,2-phenylene diacetateMeSH

  structure in first source

• C5711494-(3-(2H-1,2,3-triazol-2-yl)phenylamino)-2-(2-aminocyclohexylamino)pyrimidine-5-carboxamideMeSH

  a spleen tyrosine kinase (Syk) inhibitor; structure in first source

• C5620384-(3-(3-chloro-4-fluorophenyl)acryloyl)-1-(3-(4-hydroxy-6-azaspiro(2.5)oct-6-yl)propyl)-3-methylpiperazin-2-oneMeSH

  structure in first source

• C5810214-(3-(4-methoxyphenyl)-1H-indol-2-yl)benzenesulfonamideMeSH

  structure in first source

• C5708194-(3-(benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidineMeSH
• D0123684-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinoneMeSH

  Inhibitor of phosphodiesterases.

• C5685474-(3-benzoyl-2-methyl-5-phenyl-1H-pyrrol-1-yl)-2-hydroxybenzoic AcidMeSH

  structure in first source

• C5877314-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)-N-(4-methoxypyridin-2-yl)piperazine-1-carbothioamideMeSH

  inhibits phosphopantetheinyl transferase; structure in first source

• C5684454-(3-cyclopropyl-1-(methylsulfonylmethyl)-5-methyl-1H-pyrazol-4-yl)oxy-2,6-dimethylbenzonitrileMeSH

  structure in first source

• C5718224-(3-ethylthiophenyl)-2-(3-thienyl)-1H-imidazoleMeSH

  structure in first source

• C5826224-(3-fluoro-4- methoxyphenyl)-N-(4-phenoxyphenyl)-1,3-thiazol-2-amineMeSH

  an aminothiazole that inhibits of microsomal prostaglandin E synthase-1

• C5864564-(3-fluoro-8-oxatricyclo(7.5.0.02,7)tetradeca-2,4,6-trien-1-yl)phenolMeSH

  structure in first source

• C5829224-(3-fluoroazetidin-1-yl)-7-methyl-5-(1-methyl-5-(4-(trifluoromethyl)phenyl)-1H-pyrazol-4-yl)imidazo(5,1-f)(1,2,4)triazineMeSH

  a PET radioligand for phosphodiesterase 2A; structure in first source

• C5858554-(3-fluorobenzylideneamino)antipyrineMeSH

  structure in first source

• C5839974-(3-hydroxy-4-methoxyphenyl)-3-(4-hydroxyphenyl)-1-(3,4,5-trimethoxyphenyl)azetidin-2-oneMeSH

  structure in first source

• C5756344-(3-isopropyl-1,2,4-oxadiazol-5-yl)-N-(trans-2-phenylcyclopropyl)piperidine-1-carboxamideMeSH

  structure in first source

• C5751594-(3-isopropyl-5-(6-phenyl-3-pyridyl)-4H-1,2,4-triazol-4-yl)-2,1,3-benzoxadiazoleMeSH

  inhibits glycine transporter 1; structure in first source

• C5718984-(3-thioxo-3H-1,2-dithiol-5-yl)phenyl 2-((4-(nitrooxy)butanoyl)oxy)benzoateMeSH

  releases both nitric oxide and hydrogen sulfide; structure in first source

• C5831054-(4'-hydroxybenzyl)phenyl glucosideMeSH

  isolated from the rhizomes of Gastrodia elata; structure in first source

• C5827814-(4'-iodobiphenyl-4-yl)-N-octyl-4-oxobutanamideMeSH

  a SPECT tracer for imaging COX enzyme-expressing tumors; structure in first source

• C5610304-(4,6-di(2,2,2-trifluoroethoxy)-1,3,5-triazin-2-yl)-4-methylomorpholinium tetrafluoroborateMeSH

  structure in first source

• C5617614-(4-((1-butyl-3-(cyclohexyl(hydroxy)methyl)-2,5-dioxo-1,4,9-triazaspiro(5.5)undec-9-yl)methyl)phenoxy)benzoic acidMeSH
• C5685174-(4-((2',3',4',6'-tetra-O-acetylglucopyranosyl)thiomethyl)-5-iodo-1-H-1,2,3-triazol-1-yl)benzenesulfonamideMeSH

  inhibit carbonanhydrase IX, structure in first source

• C5774894-(4-((4-chloro-3-ethyl-1-methylpyrazol-5-yl)carbonylaminomethyl)phenoxy)benzoic acidMeSH

  major metabolite of tolfenpyrad; structure in first source

• C5845094-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acidMeSH

  a potent and specific inhibitor of p300/CBP HAT activity

• C5685184-(4-((glucopyranosyl)thiomethyl)-5-iodo-1-H-1,2,3-triazol-1-yl)benzenesulfonamideMeSH

  inhibits carbonic anhydrase IX; structure in first source

• C5868444-(4-((thiiran-2-ylmethyl)sulfonyl)phenoxy)phenyl ethylcarbamateMeSH

  an MMP-2 inhibitor; structure in first source

• C5756314-(4-(2,4-dioxothiazolidin-5-ylidenemethyl)-2-methoxyphenoxy)-3-trifluoromethylbenzonitrileMeSH

  an estrogen-related receptor alpha ligand with antidiabetic activity; structure in first source

• C5729614-(4-(3-(4-trifluoromethoxy-phenyl)ureido)cyclohexyloxy)benzoic acidMeSH
• C5831264-(4-(3-hydroxyphenyl)-3-(4-methylphenyl)-6-oxo-1H,4H,5H,6H-pyrrolo(3,4-c)pyrazol-5-yl)benzoic acidMeSH

  a GPR55 antagonist; structure in first source

• C5810094-(4-(3-methylmorpholin-4-yl)-6-(1-(methylsulfonyl)cyclopropyl)pyrimidin-2-yl)-1H-indoleMeSH

  an antineoplastic agent that inhibits ATR protein kinase; structure in first source

• C5762244-(4-(4-chlorophenyl)-1,4-diazepan-1-yl)-1-(4-fluorophenyl)butan-1-oneMeSH

  an antipsychotic agent; structure in first source

• C5702844-(4-(4-chlorophenyl)-5-(1,2,3)triazol-2-ylmethyl-4H-(1,2,4)triazol-3-yl)piperidin-1-yl-(3,5-difluorophenyl)methanoneMeSH

  a vasopressin V(1A) receptor antagonist; structure in first source

• C5844624-(4-(4-dimethylaminophenyl)-5-phenyl-1H-imidazol-2-yl)benzoic acid methyl esterMeSH

  binds human serum albumin; structure in first source

• C5829904-(4-(aminomethyl)-7a-methyl-1-methylideneoctahydro-1H-inden-5-yl)-3-(hydroxymethyl)-4-methylcyclohexan-1-olMeSH

  inhibits SH2-containing inositol-5'-phosphatase 1 (SHIP1); structure in first source

• C5726324-(4-(dimethylamino)phenyl)-1-methylpyridiniumMeSH

  a fluorescent substrate for the serotonin transporter; structure in first source

• C5771104-(4-(hydroxymethyl)-3-methyl-2,5-dioxo-4-phenylimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrileMeSH

  structure in first source

• C5620354-(4-(toluene-4-sulfonyl)-2,3,4,5-tetrahydrobenzo(f)(1,4)oxazepin-3-ylmethyl)phenolMeSH

  has antineoplastic activity; structure in first source

• C5845544-(4-(trifluoromethyl)phenyl)-N-(6-fluoro-1H-indazol-5-yl)-2-methyl-6-oxo-1,4,5,6-tetrahydro-3-pyridinecarboxamideMeSH

  a Rho kinase inhibitor

• C5782014-(4-bromophenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinoline-8-sulfonamideMeSH

  an alpha7 nicotinic receptor agonist; structure in first source

• C5767594-(4-bromophenyl)-5-(3-chlorophenyl)-2,4-dihydro-3H-1,2,4-triazole-3-thioneMeSH

  structure in first source